ABI

Adamant Biomedical Investments Portfolio holdings

AUM $418M
This Quarter Return
+10.95%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$418M
AUM Growth
+$418M
Cap. Flow
-$21.3M
Cap. Flow %
-5.1%
Top 10 Hldgs %
32.81%
Holding
108
New
12
Increased
10
Reduced
35
Closed
7

Top Buys

1
HSP
HOSPIRA INC
HSP
$5.51M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
$5.4M
3
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$4.71M
4
MDVN
MEDIVATION, INC.
MDVN
$4.48M
5
LGND icon
Ligand Pharmaceuticals
LGND
$4.33M

Top Sells

1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$5.12M
2
BIB icon
ProShares Ultra NASDAQ Biotechnology
BIB
$4.39M
3
TEVA icon
Teva Pharmaceuticals
TEVA
$4.03M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
$3.82M
5
QGENF
QIAGEN NV
QGENF
$3.53M

Sector Composition

1 Healthcare 87.28%
2 Financials 0.93%
3 Industrials 0.35%
4 Technology 0.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MDCO
76
DELISTED
Medicines Co
MDCO
$1.38M 0.33%
50,000
– –
SGEN
77
DELISTED
Seagen Inc. Common Stock
SGEN
$1.29M 0.31%
40,000
– –
ACHN
78
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$1.23M 0.29%
100,000
+20,000
+25% +$245K
NPSP
79
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.22M 0.29%
34,000
– –
RMD icon
80
ResMed
RMD
$39.7B
$1.12M 0.27%
20,000
-39,450
-66% -$2.21M
COV
81
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.02M 0.24%
10,000
-50,000
-83% -$5.12M
NBIX icon
82
Neurocrine Biosciences
NBIX
$14.1B
$1.01M 0.24%
45,000
– –
UTHR icon
83
United Therapeutics
UTHR
$18.3B
$906K 0.22%
7,000
-8,000
-53% -$1.04M
COR icon
84
Cencora
COR
$57.2B
$902K 0.22%
10,000
– –
MYGN icon
85
Myriad Genetics
MYGN
$642M
$817K 0.2%
24,000
– –
IMMU
86
DELISTED
Immunomedics Inc
IMMU
$720K 0.17%
150,000
– –
WCG
87
DELISTED
Wellcare Health Plans, Inc.
WCG
$656K 0.16%
8,000
– –
IPXL
88
DELISTED
Impax Laboratories, Inc.
IPXL
$634K 0.15%
20,000
– –
IQV icon
89
IQVIA
IQV
$31.2B
$589K 0.14%
+10,000
New +$589K
HALO icon
90
Halozyme
HALO
$8.58B
$579K 0.14%
60,000
– –
CLDX icon
91
Celldex Therapeutics
CLDX
$1.46B
$548K 0.13%
30,000
– –
INVA icon
92
Innoviva
INVA
$1.32B
$495K 0.12%
35,000
-65,000
-65% -$919K
AFFX
93
DELISTED
AFFYMETRIX INC
AFFX
$494K 0.12%
50,000
-50,000
-50% -$494K
EXEL icon
94
Exelixis
EXEL
$10B
$432K 0.1%
300,000
– –
INFI
95
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$287K 0.07%
17,000
– –
IMS
96
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$256K 0.06%
+10,000
New +$256K
TBPH icon
97
Theravance Biopharma
TBPH
$697M
$171K 0.04%
11,428
– –
GERN icon
98
Geron
GERN
$938M
$146K 0.03%
45,000
– –
AST
99
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$6K ﹤0.01%
+1,875
New +$6K
BTX.WS
100
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$2K ﹤0.01%
+2,294
New +$2K
1 2 3
4
5